BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 34036731)

  • 1. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease.
    Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W
    ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of edaravone derivatives bearing the
    Zondagh LS; Malan SF; Joubert J
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1596-1605. PubMed ID: 32779503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
    Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
    Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
    Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lathyrane and premyrsinane Euphorbia diterpenes against Alzheimer's disease: Bioinspired synthesis, anti-cholinesterase and neuroprotection bioactivity.
    Sun L; Wang XM; Tang Q; Xiao Y; Xu JB; Zhang TT; Liu YJ; Li X; Gao F
    Bioorg Chem; 2024 Jun; 147():107377. PubMed ID: 38653150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
    Cavdar H; Senturk M; Guney M; Durdagi S; Kayik G; Supuran CT; Ekinci D
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):429-437. PubMed ID: 30734597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors.
    Shi YF; Zhang HY; Wang W; Fu Y; Xia Y; Tang XC; Bai DL; He XC
    Acta Pharmacol Sin; 2009 Aug; 30(8):1195-203. PubMed ID: 19578388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity.
    Zhang LJ; Zhang HZ; Liu YW; Tang M; Jiang YJ; Li FN; Guan LP; Jin QH
    Neurochem Res; 2024 Jun; 49(6):1592-1602. PubMed ID: 38305960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation.
    Mishra CB; Shalini S; Gusain S; Kumar P; Kumari S; Choi YS; Kumari J; Moku BK; Yadav AK; Prakash A; Jeon R; Tiwari M
    Biomed Pharmacother; 2024 May; 174():116484. PubMed ID: 38565058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into the Marine Alkaloid Discorhabdin G as a Scaffold towards New Acetylcholinesterase Inhibitors.
    Defant A; Carloni G; Innocenti N; Trobec T; Frangež R; Sepčić K; Mancini I
    Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates.
    Soni A; Kumar A; Kumar V; Rawat R; Eyupoglu V
    Future Med Chem; 2024 Mar; 16(6):513-529. PubMed ID: 38375588
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Acetylcholinesterase by Novel Lupinine Derivatives.
    Schepetkin IA; Nurmaganbetov ZS; Fazylov SD; Nurkenov OA; Khlebnikov AI; Seilkhanov TM; Kishkentaeva AS; Shults EE; Quinn MT
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase.
    Chung YK; Heo HJ; Kim EK; Kim HK; Huh TL; Lim Y; Kim SK; Shin DH
    Mol Cells; 2001 Apr; 11(2):137-43. PubMed ID: 11355692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells.
    Heo HJ; Hong SC; Cho HY; Hong B; Kim HK; Kim EK; Shin DH
    Mol Cells; 2002 Feb; 13(1):113-7. PubMed ID: 11911460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of newly synthesized benzimidazole derivative for anti-Alzheimer potential.
    Ahmed A; Khan AU; Nadeem H; Imran M; Irshad N
    Int J Neurosci; 2024 Jun; 134(6):635-651. PubMed ID: 36259511
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing drug-like properties of selective butyrylcholinesterase inhibitors for cognitive improvement: Enhancing aqueous solubility by disrupting molecular plane.
    Xing S; Tang X; Wang L; Wang J; Lv B; Wang X; Guo C; Zhao Y; Feng F; Liu W; Chen Y; Sun H
    Eur J Med Chem; 2024 Mar; 268():116289. PubMed ID: 38452730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (+)-Arisugacin A--computational evidence of a dual binding site covalent inhibitor of acetylcholinesterase.
    Al-Rashid ZF; Hsung RP
    Bioorg Med Chem Lett; 2011 May; 21(9):2687-91. PubMed ID: 21216144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System.
    Akimov MG; Kudryavtsev DS; Kryukova EV; Fomina-Ageeva EV; Zakharov SS; Gretskaya NM; Zinchenko GN; Serkov IV; Makhaeva GF; Boltneva NP; Kovaleva NV; Serebryakova OG; Lushchekina SV; Palikov VA; Palikova Y; Dyachenko IA; Kasheverov IE; Tsetlin VI; Bezuglov VV
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection of macamide in a mouse model of Alzheimer's disease involves Nrf2 signaling pathway and gut microbiota.
    Xia N; Xu L; Huang M; Xu D; Li Y; Wu H; Mei Z; Yu Z
    Eur J Pharmacol; 2024 Jul; 975():176638. PubMed ID: 38734297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings.
    Kuca K; Karasova JZ; Soukup O; Kassa J; Novotna E; Sepsova V; Horova A; Pejchal J; Hrabinova M; Vodakova E; Jun D; Nepovimova E; Valis M; Musilek K
    Drug Des Devel Ther; 2018; 12():505-512. PubMed ID: 29563775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.